MedPath

Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)

Phase 3
Completed
Conditions
Chronic Kidney Disease
Interventions
Device: Video Telemonitoring Device with Clinical Care Modules
Registration Number
NCT01446029
Lead Sponsor
Minneapolis Veterans Affairs Medical Center
Brief Summary

The purpose of this study is to determine if the adoption of a chronic care model in conjunction with tele monitoring and case management can reduce the risk of death, hospitalization, emergency room visits, or admission to a skilled nursing facility in patients with chronic kidney disease compared to usual care.

Detailed Description

Chronic kidney disease (CKD) is a major public health issue. Approximately, 11% of the US population has CKD with an increased prevalence among individuals great than 65years. Many individuals with CKD go unrecognized because they are typically asymptomatic. Individuals with CKD have been demonstrated to have a greater risk for mortality, hospitalization and development of end stage kidney disease. Also, individuals with CKD consume a significantly greater proportion of health care expenditures compared to other patients. This study aims to determine if the adoption of a chronic care model in conjunction with telemonitoring and case management can reduce risk of death, hospitalization, ER visits or admission to a skilled nursing facility in patients with CKD compared to usual care. This study will use a randomized controlled trial. Few interventions have been demonstrated to improve clinical outcomes in patients with CKD. If successful, this study will enable the VA to provide high quality care to patients with CKD while potentially reducing the cost of providing care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
601
Inclusion Criteria

Enrolled at Minneapolis or St. Cloud Veterans Affairs Health Care System (VAHCS) or affiliated Community Based Outcomes Clinic(CBOC); Late eGFR within the VA system <60 ml/min/1.73m2 -

Exclusion Criteria

Primary care provider unwilling to have participant included in study; unable to give consent; severe mental health condition; living in a nursing home

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention DeviceVideo Telemonitoring Device with Clinical Care Modules-
Primary Outcome Measures
NameTimeMethod
composite clinical outcome (reduce risk of death, hospitalization, emergency room visits, admission to skilled nursing facility)one year
Secondary Outcome Measures
NameTimeMethod
reduction of costone year
incidence of end stage kidney diseaseone year
hospital re-admissionone year
Intervention group achieving National Kidney guideline values for blood pressure, glycemia, lipids, and hemoglobinone year

Trial Locations

Locations (1)

VA Medical Center

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath